psoriatic%20arthritis
PSORIATIC ARTHRITIS
Psoriatic arthritis is a chronic inflammatory arthropathy associated with cutaneous psoriasis.
It is a progressive disease with asymmetric joint distribution pattern and rheumatoid factor is negative.
It can develop at any time including childhood but most often occurs between 30-50 years old.
Symptoms may range from mild to very severe.

Patient Education

  • Explain what psoriatic arthritis is all about, its relation to psoriasis & its unpredictable, recurring nature
  • Explain that psoriatic arthritis is a long term, progressive disease but can be managed w/ appropriate therapy
  • Discuss the quality of life issues & reassure them that these issues may not be present in every case
    • Pain & fatigue
    • Employment problems & managing therapy while at work
    • Possible stigma & impact on daily tasks
    • Family life & relationships
    • Emotional issues (eg depression, anxiety & stress)
  • Inform about the increased risk of comorbid conditions (eg cardiovascular disease, diabetes) & the need for regular follow-up & screening
  • Encourage a healthy lifestyle
    • Regular exercise
    • Weight management (aim for BMI 18.5-24.9)
    • Smoking cessation
    • Alcohol restriction
    • Blood pressure control
  • Emphasize the goal of therapy is to control joint pain, stiffness & damage in order to improve the quality of life & prevent long-term disability
  • Discuss the various treatment options & ensure that the patient is part of the decision making
  • Explain the benefits, adverse effects & risks of therapy to help the patients make an informed consent
  • Explain the importance of compliance to the therapy & discuss how to overcome the potential problems about adherence
  • Discuss the requirements for monitoring & assessment of the disease & their results
  • Identify & avoid triggering factors
  • Develop strategies to cope w/ flare-ups
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Audrey Abella, 14 Sep 2017
The interleukin-6 receptor-alpha inhibitor tocilizumab alone or in combination with methotrexate demonstrated clinical benefit after 2 years of treatment in methotrexate-naïve patients with early rheumatoid arthritis (RA), according to the FUNCTION* trial.